In this episode, we speak with Michelle Lee, PwC's US Pharmaceutical and Life Sciences Tax Leader, to discuss the business and tax issues in one of the most high-profile industries during the pandemic, pharmaceuticals and life sciences (including medical devices). We will cover the general state of the industry, operational impacts due to supply chain disruption, the impact of US election and global reform as well as the influence of technology on audit and reputational risk. Featuring:
